首页 › 基金 › ESSEX INVESTMENT MANAGEMENT CO LLC › KNSA
ESSEX INVESTMENT MANAGEMENT CO LLC 对 KNSA 的持仓历史
KINIKSA PHARMACEUTICALS INTL P ORD SHS CL A · 医疗保健
ESSEX INVESTMENT MANAGEMENT CO LLC 在 Q3 2026 的 13F 申报中披露持有 KNSA(KINIKSA PHARMACEUTICALS INTL P ORD SHS CL A)202,021 股,市值约 US$15.1M,约占其申报组合的 2.24%,在其申报持仓中市值排名第 2 位。 ESSEX INVESTMENT MANAGEMENT CO LLC 最近 13 个申报季度中有 13 个季度披露了 KNSA 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-10-21 · 来源: SEC EDGAR Form 13F-HR
ESSEX INVESTMENT MANAGEMENT CO LLC 对 KNSA 的持仓演变
ESSEX INVESTMENT MANAGEMENT CO LLC 于 Q3 2023 首次披露 KNSA 持仓:185,853 股(约 US$3.2M)。 该持仓在 Q2 2026 达到峰值 241,382 股,市值约 US$15.4M。 在 13 次申报中,ESSEX INVESTMENT MANAGEMENT CO LLC 3 次增持、7 次减持、2 次保持不变。 最近一期申报(Q3 2026)显示持股 202,021 股、市值约 US$15.1M,环比减持 -39,361 股。。 持仓曾出现大幅变动:Q3 2025 增持约 44% (随后一个季度股价上涨 6%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 185.85K | $3.23M | 新进 |
| Q4 2023 | 171.89K | $3.01M | 减持 |
| Q1 2024 | 172.74K | $3.41M | 持有 |
| Q2 2024 | 199.80K | $3.73M | 增持 |
| Q3 2024 | 200.52K | $5.01M | 持有 |
| Q4 2024 | 173.80K | $3.44M | 减持 |
| Q1 2025 | 172.67K | $3.83M | 减持 |
| Q2 2025 | 171.44K | $4.74M | 减持 |
| Q3 2025 | 247.30K | $9.60M | 增持 |
| Q4 2025 | 250.97K | $10.35M | 增持 |
| Q1 2026 | 249.28K | $12.00M | 减持 |
| Q2 2026 | 241.38K | $15.44M | 减持 |
| Q3 2026 | 202.02K | $15.07M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 KNSA 与 13F 数据
KNSA(KINIKSA PHARMACEUTICALS INTL P ORD SHS CL A)属于医疗保健行业。我们追踪的基金中还有 48 只申报持有 KNSA,申报仓位最大的包括:Rubric Capital Management LP (US$255.8M), BAKER BROS. ADVISORS LP (US$181.3M), TANG CAPITAL MANAGEMENT LLC (US$144.5M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 KNSA 的基金
- Rubric Capital Management LP 4.00M 股 · $255.79M · Q2 2026
- BAKER BROS. ADVISORS LP 2.83M 股 · $181.28M · Q2 2026
- TANG CAPITAL MANAGEMENT LLC 2.26M 股 · $144.52M · Q2 2026
- Spruce Street Capital LP 918.07K 股 · $58.71M · Q2 2026
- RICE HALL JAMES & ASSOCIATES, LLC 624.93K 股 · $39.96M · Q2 2026
- ORBIMED ADVISORS LLC 420.60K 股 · $26.90M · Q2 2026
- Penn Capital Management Company, LLC 368.11K 股 · $23.57M · Q2 2026
- Soleus Capital Management, L.P. 246.35K 股 · $15.75M · Q2 2026
- ArrowMark Colorado Holdings LLC 215.55K 股 · $13.78M · Q2 2026
- STEMPOINT CAPITAL LP 209.23K 股 · $13.38M · Q2 2026
更多关于 ESSEX INVESTMENT MANAGEMENT CO LLC
常见问题
How long has ESSEX INVESTMENT MANAGEMENT CO LLC held KNSA?
ESSEX INVESTMENT MANAGEMENT CO LLC has disclosed KNSA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is ESSEX INVESTMENT MANAGEMENT CO LLC's current position in KNSA?
As of Q3 2026, ESSEX INVESTMENT MANAGEMENT CO LLC holds 202.02K shares of KNSA (KINIKSA PHARMACEUTICALS INTL P ORD SHS CL A), valued at $15.07M, representing 2.24% of its reported portfolio and ranking #2.
Has ESSEX INVESTMENT MANAGEMENT CO LLC been buying or selling KNSA?
In the latest 13F filing (Q3 2026), ESSEX INVESTMENT MANAGEMENT CO LLC reduced its position in KNSA. The position peaked in Q2 2026 at 241.38K shares.
Which other funds hold KNSA?
Other major institutional holders of KNSA include Rubric Capital Management LP, BAKER BROS. ADVISORS LP, TANG CAPITAL MANAGEMENT LLC, among 48 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.